Exact Sciences Corporation (EXAS)
$104.91+0.00%Close
BUYBULL · day 78
Key stats
- Market cap
- $20.0B
- Avg volume
- 2.5M
- Beta
- 1.44
- P/E (TTM)
- -95.69
- 1W
- +1.02%
- 1M
- +1.43%
- 3M
- +3.48%
- YTD
- +3.12%
- vs SPY 1W
- +2.21%
- vs SPY 1M
- -1.89%
- vs SPY 3M
- +1.09%
- vs SPY YTD
- -8.64%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- VXRTSELLVaxart, Inc.RECOVERYQ 1$0.51-1.92%
- CGENBUYCompugen Ltd.RECOVERYQ 11$2.59-1.15%
- MGTXBUYMeiraGTx Holdings plcBULLQ 9$14.83+3.42%
- MASIBUYMasimo CorporationBULLQ 14$179.95+0.00%
- CNCBUYCentene CorporationBULLQ 15$65.65+0.97%
- ORMPBUYOramed Pharmaceuticals Inc.RECOVERYQ 7$4.82+0.21%
- BHCBUYBausch Health Companies Inc.RECOVERYQ 1$6.68+3.73%
- SEMSELLSelect Medical Holdings CorporationBULLQ 9$16.51-0.12%
- AVNSSELLAvanos Medical, Inc.BULLQ 10$24.99+0.04%
- THCBUYTenet Healthcare CorporationBULLQ 11$278.59-0.78%
- RDNTBUYRadNet, Inc.RECOVERYQ 24$74.69-2.77%
- EVHBUYEvolent Health, Inc.RECOVERYQ -6$4.72-0.42%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDBUYRevolution Medicines, Inc.$45.0BBULLQ 31$211.74+1.01%
- ROIVBUYRoivant Sciences Ltd.$26.6BBULLQ 31$36.84+0.17%
- GHBUYGuardant Health, Inc.$22.5BBULLQ 23$167.88-4.40%
- VTRSSELLViatris Inc.$18.8BBEARQ 4$16.12+1.35%
- BBIOSELLBridgeBio Pharma, Inc.$16.2BRECOVERYQ 20$82.94-0.53%
- RVTYBUYRevvity, Inc.$13.8BBULLQ 10$124.13-1.40%
- ICLRBUYICON Public Limited Company$13.3BRECOVERYQ 18$174.26+0.73%
- SMMTSELLSummit Therapeutics Inc.$9.9BCRISISQ 16$12.43-3.27%
- QGENBUYQiagen N.V.$9.3BRECOVERYQ 15$44.90-5.20%
- DOCSSELLDoximity, Inc.$4.9BRECOVERYQ 5$25.94-0.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 36
- VALUE
- 12
- GROWTH
- 32
- GARP
- 38
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-5.1%
REV YoY-
ROE-8.5%
EPS YoY-
ROA-3.5%
GROSS70
OP-6
NET-6
[VALUATION]
P/E TTM-95.69
P/E FWD108.68
SECTOR PE22.62
INDUSTRY PE31.31
P/B8.29
P/FCF-
EV/EBITDA397.39
EV/EBIT-
PEG2.59
FCF YIELD-
RISK
INT COV-
D/E105.07
ALTMAN Z-
CURR RATIO2.23
ND/EBITDA-
BETA1.44
